Work

Cognitive effects of darolutamide vs enzalutamide: Results of ARACOG (AFT-47), a randomized clinical trial from the Alliance for Clinical Trials in Oncology.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5005

Authors: Alicia K. Morgans, Olivia Bobek, Daniel H. Kwon, Stephanie A. Berg, Deepak Kilari, Russell Zelig Szmulewitz, Stuart H. Bloom, Elizabeth Wulff, Praful Ravi, Daniel Aaron Roberts, Karla V. Ballman, Emmanuel S. Antonarakis, Charles J. Ryan

Institutions: Harvard University, Dana-Farber Cancer Institute, Mayo Clinic, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of Chicago Medical Center, University of Minnesota, University of Kansas Medical Center, Masonic Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer-related cognitive impairment studies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Prostate Cancer Foundation

OpenAlex ID: W7162486150

Cites:

Cited by: 4

Related to: